278 A.3d 696
D.C.2022Background
- Ishakwue, a probationary Clinical Nurse II at DYRS, raised concerns in Dec. 2015–Jan. 2016 about two youths who had PPD readings and one who reported coughing blood; she contends DYRS failed to isolate or follow up per TB protocols.
- DYRS supervisors (Nurse Jackson and Dr. Bellard) treated the youths as unlikely to have active, contagious TB: no other symptoms, TB rare in healthy youths, and clinicians had exercised medical judgment (QuantiFERON ordered for one youth).
- Appellant alleges her disclosures to supervisors and to D.C. DOH were protected under the D.C. Whistleblower Protection Act (WPA) because she reasonably believed they evidenced a substantial and specific danger to public health and safety.
- DYRS terminated Ishakwue during her probationary year; she sued under the WPA. A jury found her disclosures were not "protected disclosures," so did not reach causation or affirmative-defense issues. Trial court denied JNOV/new-trial motion.
- On appeal the D.C. Court of Appeals affirmed: the record supported the jury’s finding that the disclosures were not objectively reasonable protected disclosures, and the trial court did not abuse its discretion in excluding certain post-termination DOH reports and Jerry M. materials.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether the first TB disclosure (youth reporting coughing blood; alleged 15 mm PPD) was a "protected disclosure" under the WPA | Ishakwue: coughing blood plus a 15 mm PPD made it objectively reasonable for a nurse to believe the youth was contagious and posed a substantial, specific danger. | District: coughing blood is non-determinative; TB is rare in healthy youths; no other signs of active TB; timing/documentation of the PPD result was unclear. | Court: Jury reasonably could reject protection; affirmed. |
| Whether the second TB disclosure (12 mm PPD) was a "protected disclosure" | Ishakwue: 12 mm and DOH advice showed the youth required follow-up and treatment; concern was reasonable. | District: DYRS standard for healthy youths was 15 mm; 12 mm not conclusively positive; no other symptoms; clinical discretion justified actions. | Court: Credible evidence supported jury rejection; affirmed. |
| Whether the trial court erred by excluding DOH investigative reports and evidence relating to the Jerry M. consent decree | Ishakwue: DOH reports and Jerry M. materials corroborate systemic failures and bolster reasonableness of her belief. | District: Reports post-date the relevant disclosures or are not tied to what Ishakwue knew; Jerry M. materials are remote and of limited relevance and prejudicial. | Court: Exclusion was not an abuse of discretion; reports did not clearly support the required contemporaneous, objectively reasonable belief; affirmed. |
| Whether JNOV or a new trial was required because the verdict was against the weight of the evidence | Ishakwue: evidence conclusively established protected disclosures and exclusion of evidence prejudiced her case. | District: Conflicting testimony and documentary gaps permitted a jury finding for the District; standard of review requires deference to reasonable jurors. | Court: Applying de novo review for JNOV but deferring to reasonable jury inferences, affirmed denial of JNOV/new trial. |
Key Cases Cited
- District of Columbia v. Poindexter, 104 A.3d 848 (D.C. 2014) (JNOV standard and WPA protected-disclosure evidentiary requirements)
- Ukwuani v. District of Columbia, 241 A.3d 529 (D.C. 2020) (WPA: sincerity and objective reasonableness standard; jury role in protected-disclosure determinations)
- Zirkle v. District of Columbia, 830 A.2d 1250 (D.C. 2003) (disinterested-observer test for reasonableness of whistleblower belief)
- Lachance v. White, 174 F.3d 1378 (Fed. Cir. 1999) (definition of "reasonable" in similar federal WPA context)
- Freeman v. District of Columbia, 60 A.3d 1131 (D.C. 2013) (employee cannot ignore readily ascertainable facts that would refute a whistleblower claim)
- Chambers v. Department of the Interior, 602 F.3d 1370 (Fed. Cir. 2010) (substantial-and-specific-danger requirement under federal WPA standard)